Publicaciones en las que colabora con Jesús J. Sola (22)

2015

  1. Immune monitoring of immunosuppression withdrawal of liver transplant recipients

    Transplant Immunology, Vol. 33, Núm. 2, pp. 110-116

2014

  1. Characterization of the CD40L/Oncostatin M/Oncostatin M receptor axis as an antiviral and immunostimulatory system disrupted in chronic HCV infection

    Journal of Hepatology, Vol. 60, Núm. 3, pp. 482-489

  2. Is liver biopsy necessary in the evaluation of a living donor for liver transplantation?

    Transplantation Proceedings

2013

  1. Long-term follow-up study of gastroduodenal lesions after radioembolization of hepatic tumors

    World Journal of Gastroenterology, Vol. 19, Núm. 19, pp. 2935-2940

  2. Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance

    Liver Transplantation, Vol. 19, Núm. 9, pp. 937-944

2011

  1. MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells

    Stem Cells, Vol. 29, Núm. 11, pp. 1661-1671

2009

  1. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells

    Clinical Cancer Research, Vol. 15, Núm. 7, pp. 2281-2290

2008

  1. Liver disease induced by radioembolization of liver tumors: Description and possible risk factors

    Cancer, Vol. 112, Núm. 7, pp. 1538-1546

2007

  1. Gastroduodenal injury after radioembolization of hepatic tumors

    American Journal of Gastroenterology, Vol. 102, Núm. 6, pp. 1216-1220

  2. Induction of immunosuppressive molecules and regulatory T cells counteracts the antitumor effect of interleukin-12-based gene therapy in a transgenic mouse model of liver cancer

    Journal of Hepatology, Vol. 47, Núm. 6, pp. 807-815

2005

  1. Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas

    Journal of Clinical Oncology, Vol. 23, Núm. 5, pp. 999-1010

2004

  1. Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors

    Journal of Clinical Oncology, Vol. 22, Núm. 8, pp. 1389-1397

2003

  1. A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis

    Gastroenterology, Vol. 124, Núm. 4, pp. 1037-1042

2001

  1. Idiopathic adulthood ductopenia. Long-term follow-up after liver transplantation

    Digestive Diseases and Sciences, Vol. 46, Núm. 7, pp. 1420-1423

1999

  1. Severe hepatotoxicity caused by amiodarone: description of a case

    Revista de medicina de la Universidad de Navarra, Vol. 43, Núm. 2, pp. 86-91

1998

  1. Effectiveness of lamivudine in treatment of acute recurrent hepatitis B after liver transplantation

    Digestive Diseases and Sciences, Vol. 43, Núm. 6, pp. 1186-1189

  2. Risk factors for recurrence of hepatitis C after liver transplantation

    Liver Transplantation and Surgery, Vol. 4, Núm. 4, pp. 265-270

1994

  1. Percutaneous transhepatic stenting by wallstents of portal vein and bile duct stenoses caused by immunoblastic sarcoma in a liver transplantation

    CardioVascular and Interventional Radiology, Vol. 17, Núm. 4, pp. 210-213

  2. Transvenous Liver Biopsy in Patients with Cirrhosis with Use of the Femoral Venous Approach and a Flexible Forceps

    Journal of Vascular and Interventional Radiology, Vol. 5, Núm. 3, pp. 460-462

1992

  1. Leukotriene C4 detection as an early graft function marker in liver transplantation

    Transplantation Proceedings